Clinical Trial Update: Safety and Pharmacokinetics Study of Naldemedine in Paediatric Participants Receiving Opioids [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 safety and pharmacokinetics study of naldemedine in pediatric participants receiving opioids for opioid-induced constipation; the trial is currently r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid-induced Constipation

Drugs mentioned

• Symproic (Naldemedine) (Naldemedine)

Snippet

Sponsor: Shionogi | Conditions: Opioid-Induced Constipation (OIC) | Phase 1, Phase 2 | Status: RECRUITING